[ Price : $8.95]
FDA solicits comments on using technologies and innovative methods in clinical investigations.[ Price : $8.95]
FDA releases an FDS-483 detailing 13 violations found in a Noven Pharmaceuticals inspection.[ Price : $8.95]
Stakeholders express concerns about an FDA draft guidance on biologic naming.[ Price : $8.95]
A Kaiser Family Foundation health tracking poll finds that people think drug companies spend too much on advertising to patients a...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on an information collection on investigational device exemptions reports and records.[ Price : $8.95]
FDA and Pacira Pharmaceuticals enter settlement talks to resolve a recent lawsuit or narrow the dispute brought against the agency...[ Price : $8.95]
The CDER Office of Generic Drugs issues a MAPP with the process for reviewing and approving or denying requests for consolidation ...[ Price : $8.95]
Cubist asks FDA to impose specific bioequivalence requirements on ANDA and 505(b)(2) NDA applicants citing Dificid as the referenc...